Corning just opened a new pharmaceutical vial manufacturing factory in Durham, North Carolina, where it said it can produce 500 million glass vials per year to deliver Covid-19 Vaccines and other drugs to the U.S. and abroad.
The factory was developed and deployed in record time thanks in part to the $204 million funding from the federal government as a part of Operation Warp Speed. Corning said its vials have been used for more than three billion doses of Covid-19 vaccines over the past 18 months.
Corning CEO Wendell Weeks plans to grow the pharmaceutical side of the business and said it will be “billions of dollars of opportunity” for the glass manufacturing giant. Corning’s vials borrow technology from Gorilla Glass, made for Apple iPhones, which makes them less likely to break or scratch and able to withstand the super cold temperatures needed for storing the Covid vaccine.
CNBC
Trending
- Desire Engineering: How Top Product Marketers Manufacture Demand Before Launch
- Zero Market Startups: Creating Demand for Something Nobody Asked For
- Will Generative AI Replace Programmers? The Truth Behind the Hype
- Generative AI vs Agentic AI vs AI Agents : The Future of AI
- Disruptive Pricing Models That Overthrow Established Market Leaders
- The Architecture of Agentic AI: Breaking Down the Key Components
- Disruption as a Service: Startups Built to Challenge Existing Players
- What is Agentic AI ? Understanding the Core Principles of Agentic AI